Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 5, 2010, Pages 524-532

  Fenner, Lukas ^a   Brinkhof, Martin W G ^a   Keiser, Olivia ^a   Weigel, Ralf ^b   Cornell, Morna ^c,d   Moultrie, Harry ^e   Prozesky, Hans ^f   Technau, Karl ^d   Eley, Brian ^c   Vaz, Paula ^g   Pascoe, Margaret ^h   Giddy, Janet ⁱ   Van Cutsem, Gilles ^c,d   Wood, Robin ^c   Egger, Matthias ^a   Davies, Mary Ann ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b LIGHTHOUSE TRUST   (Malawi)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g Paediatric Day Hospital   (Mozambique)

^h Newlands Clinic   (Zimbabwe)

ⁱ MCCORD HOSPITAL   (South Africa)

Author keywords

adjustment; AIDS; ART; children; heterogeneity; HIV; loss to follow up; Southern Africa; transfer out

Indexed keywords

EFAVIRENZ; LAMIVUDINE PLUS STAVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CHILDHOOD MORTALITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALAWI; MALE; MOZAMBIQUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SENSITIVITY ANALYSIS; SOUTH AFRICA; ZIMBABWE;

AFRICA, SOUTHERN; AGE FACTORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77955013307     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e0c4cf     Document Type: Article

References (38)

1. World Health Organization. Towards Universal Access. Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2008. Available at: http://www.who.int/hiv/pub/towards-universal-access- report-2008.pdf. Geneva, Switzerland: World Health Organization, UNAIDS, Unicef
2. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
3. Keiser O, Orrell C, Egger M, et al. Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med. 2008;5:e148.
4. Brinkhof MW, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6:e1000066.
5. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-567.
6. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007; 4:e298.
7. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4:e5790.
8. World Health Organization.Towards universal access by 2010: How WHO is working with countries to scale-up HIV prevention, treatment, care and support. Available at: http://www.who.int/hiv/mediacenter/universal- access-progres- report-en.pdf. Geneva, Switzerland: WHO; 2007.
9. KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
10. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298: 1888-1899.
11. Kekitiinwa A, Lee KJ, Walker AS, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49:384-392.
12. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
13. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298: 1888-1899.
14. Kekitiinwa A, Lee KJ, Walker AS, et al. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49:384-392.
15. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
16. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol. 2007;36:294-301.
17. World Health Organization. Data collector. Available at: https://extranet. who.int/datacol/WebHelp/DataCollector-OLH.htm. Accessed February 2008
18. World Health Organization.Growth reference data for 5-19 years. Available at: http://www.who.int/growthref/en/. Accessed February 2008.
19. World Health Organization. WHO child growth standards. Available at: http://www.who.int/childgrowth/standards/en/. Accessed February 2008.
20. World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Available at: www.who.int/hiv/pub/guidelines/WHOpaediatric.pdf. Accessed February 2008.
21. Royston P. Multiple imputation of missing values: an update. Stata J. 2005;5:1-14.
22. Egger M, Spycher B, Sidle J, et al. Correcting mortality for loss to follow up: a graphical approach applied to ART programmes in resource-limited settings. Presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa. Abstract WEPED173
23. World Health Organization.WHO antiretroviral therapy for infants and children 2008. Report of the WHO technical reference group, paediatric HIV/ART care guideline group meeting. Geneva, Switzerland: WHO headquarters. Available at: http://www.who.int/hiv/pub/meetingreports/art-meeting-april2008/en/index. html. Accessed May 2009.
24. Davies MA, Egger M, Keiser O, et al. Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies. Afr J AIDS Res. 2009;8:329-338.
25. Mukhuna B, McGuire M, Taremba K, et al. Outcomes of patient active tracing by lay community workers in a decentralized HIV care program of rural Malawi. Presented at: 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention; July 19-22, 2009; Cape Town, South Africa. Abstract WEPED195
26. Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Response to combination antiretroviral therapy: variation by age. AIDS. 2008;22:1463-1473.
27. Davies MA, Keiser O, Technau K et al. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737.
28. Vreeman RC, Wiehe SE, Ayaya SO, et al. Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr. 2008;49:163-170.
29. Eley B, Nuttall J. Antiretroviral therapy for children: challenges and opportunities. Ann Trop Paediatr. 2007;27:1-10.
30. Meyers T, Moultrie H, Naidoo K, et al. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis. 2007;196(Suppl 3): S474-S481.
31. Reddi A, Leeper SC, Grobler AC et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7:13.
32. Davies MA, Boulle A, Fakir T, et al. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008;8:34.
33. George E, Noel F, Bois G et al. Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis. 2007;195:1411-1418.
34. Losina E, Toure H, Uhler LM, et al. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal. PLoS Med. 2009;6:e1000173.
35. Baker SG, Wax Y, Patterson BH. Regression analysis of grouped survival data: informative censoring and double sampling. Biometrics. 1993;49: 379-389.
36. Frangakis CE, Rubin DB. Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring. Biometrics. 2001;57:333-342.
37. Geng EH, Emenyonu N, Bwana MB, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008;300:506-507.
38. Yiannoutsos CT, An MW, Frangakis CE, et al. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One. 2008;3:e3843.